Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorVLACHOS, Konstantinos
dc.contributor.authorBENALI, Karim
dc.contributor.authorDERVAL, Nicolas
dc.contributor.authorPAMBRUN, Thomas
dc.contributor.authorFRONTERA, Antonio
dc.contributor.authorYOKOYAMA, Masaaki
dc.contributor.authorKNEIZEH, Kinan
dc.contributor.authorASCIONE, Ciro
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBOUYER, Benjamin
ORCID: 0000-0002-7702-7610
dc.contributor.authorMONACO, Cinzia
dc.contributor.authorKOWALEWSKI, Christopher
dc.contributor.authorMENE, Roberto
dc.contributor.authorTZEIS, Stylianos
dc.contributor.authorVARDAS, Panagiotis
dc.contributor.authorASVESTAS, Dimitrios
dc.contributor.authorCARAPEZZI, Aline
dc.contributor.authorROUX, Jean-Rodolphe
dc.contributor.authorTIXIER, Romain
dc.contributor.authorCHAUVEL, Remi
dc.contributor.authorARNAUD, Marine
dc.contributor.authorSACRISTAN, Benjamin
dc.contributor.authorCOCHET, Hubert
dc.contributor.authorDUCHATEAU, Josselin
dc.contributor.authorSACHER, Frederic
dc.contributor.authorHOCINI, Meleze
dc.contributor.authorDA COSTA, Antoine
dc.contributor.authorHAISSAGUERRE, Michel
dc.contributor.authorJAIS, Pierre
dc.date.accessioned2025-05-26T06:50:36Z
dc.date.available2025-05-26T06:50:36Z
dc.date.issued2025-04-16
dc.identifier.issn2405-5018en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/206707
dc.description.abstractEnBACKGROUND: Although differential pacing (DP) has been conventionally used to confirm the achievement of block across linear lesion sets, high-resolution mapping (HRM)can unmask pseudoblock and persistent residual conduction across the lines. OBJECTIVES: This study aimed to compare conventional DP criteria with HRM for line assessment and to evaluate the impact of persistent residual conduction across a line on the risk of developing atrial tachycardia (AT) during follow-up. METHODS: Our study included consecutive patients who underwent AT or persistent atrial fibrillation ablation with ≥1 atrial linear lesion. We systematically evaluated the existence of a residual conduction through all linear lesions using HRM and compared this strategy with the results of DP. RESULTS: In a cohort of 102 patients, 101 cavotricuspid isthmus lines, 85 roof lines, and 84 mitral isthmus lines were systematically evaluated using DP and HRM. Among the cavotricuspid isthmus lines, 38 lines (37.6%) exhibited residual conduction as determined by HRM. In these 38 cases, DP yielded a false-positive result in 14 cases (37%). For the roof lines, 40 lines (47.1%) showed residual conduction, with DP yielding false-positive results in 16 (40%) of these cases. Regarding the mitral isthmus lines, 24 lines (28.6%) displayed residual conduction, and DP provided false-positive results in 13 (54%) of these cases. The 1-year AT-free survival rate was 95.4% in patients where all attempted lines were successfully blocked, compared to 31.9% in those with ≥1 line that remained unblocked despite multiple ablation attempts. CONCLUSIONS: The systematic use of HRM for line assessment allows to unmask a substantial proportion of pseudoblocks not identified by DP. The existence of a persistent residual conduction through a line is associated with a high risk of AT during follow-up.
dc.language.isoENen_US
dc.subject.enMarshall-PLAN
dc.subject.enAtrial Fibrillation
dc.subject.enAtrial Tachycardia
dc.subject.enAtrial Tachycardia–Free Survival
dc.subject.enCavotricuspid Isthmus
dc.subject.enDifferential Pacing
dc.subject.enEpicardial Bridging
dc.subject.enHigh-Resolution Activation Mapping
dc.subject.enLineal Lesions
dc.subject.enLinear Block
dc.subject.enMitral Isthmus
dc.subject.enPulmonary Vein Isolation
dc.subject.enResidual Conduction
dc.subject.enRoof
dc.subject.enSlow Conduction
dc.title.enHigh-Resolution Mapping vs Differential Pacing in Evaluating Atrial Linear Lesions and the Impact of Pseudoblocks on AT Risk
dc.title.alternativeJACC Clin Electrophysiolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jacep.2025.02.042en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed40243963en_US
bordeaux.journalJACC: Clinical Electrophysiologyen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamAHEAD_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-05084069
hal.version1
hal.date.transferred2025-05-26T06:50:41Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=JACC:%20Clinical%20Electrophysiology&rft.date=2025-04-16&rft.eissn=2405-5018&rft.issn=2405-5018&rft.au=VLACHOS,%20Konstantinos&BENALI,%20Karim&DERVAL,%20Nicolas&PAMBRUN,%20Thomas&FRONTERA,%20Antonio&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée